Esperion Therapeutics, Inc. Stock Performance
as on April 3, 2026 at 6:59 am IST
Day's Low
Day's High
$2.52$2.65
3.82%
Downside
1.15%
Upside
52 Week's Low
52 Week's High
$0.69$4.1873.57%
Downside
59.35%
Upside
Esperion Therapeutics, Inc. share price movements today
- Previous Close
- $2.61
- Open
- $2.55
- Volume
- 7.3M
- Day's Low - High
- $2.52 - $2.65
- 52 Week Low - High
- $0.69 - $4.18
Esperion Therapeutics, Inc. Historical Returns
- 1 Month Return
- -20.18 %
- 3 Month Return
- -29.65 %
- 1 Year Return
- + 87.77 %
- 3 Year Return
- + 64.15 %
- 5 Year Return
- -90.91 %
Esperion Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Esperion Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$703.7M
EPS (TTM)
0.0133
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.49
Industry PE ratio
-4.0719811320754715
PEG Ratio
-4.78
EBITDA
60.4M
Revenue (TTM)
403.1M
Profit Margin
-5.63%
Return On Equity TTM
-260.79%
Esperion Therapeutics, Inc. Stock Valuation
Track how Esperion Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Esperion Therapeutics, Inc. in the last 5 years
Lowest (-15.66x)
December 31, 2025
Industry (-4.07x)
April 2, 2026
Today (-3.49x)
April 2, 2026
Highest (-0.50x)
June 30, 2023
Today’s Price to Earnings Ratio: -3.49x
Esperion Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Esperion Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $703.7M | -90.91% | -3.49 | -5.63% | |
| BUY | $25.0B | NA | 20.47 | 41.94% | |
| HOLD | $15.6B | -1.94% | -21.95 | -24.58% | |
| BUY | $44.6B | NA | 20.43 | 15.11% | |
| BUY | $52.1B | -25.71% | 19.67 | 28.24% |
Stock Returns calculator for Esperion Therapeutics, Inc. Stock including INR - Dollar returns
The Esperion Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Esperion Therapeutics, Inc. investment value today
Current value as on today
₹2,05,363
Returns
₹1,05,363
(+105.36%)
Returns from Esperion Therapeutics, Inc. Stock
₹88,489 (+88.49%)
Dollar Impact
₹16,874 (+16.87%)
Analyst Recommendation on Esperion Therapeutics, Inc. Stock
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Esperion Therapeutics, Inc.. Average target price of $6.99
Esperion Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Esperion Therapeutics, Inc..
What analysts predicted
62.52%UPSIDE
Target Price
$6.99
Current Price
$2.62
Analyzed by
14 Analysts
Target
$6.99
Esperion Therapeutics, Inc. target price $6.99, a slight upside of 62.52% compared to current price of $2.62. According to 14 analysts rating.
Esperion Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Esperion Therapeutics, Inc. Stock has increased by 117% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:117% versus previous 30 day period
Esperion Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Esperion Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Esperion Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Esperion Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Esperion Therapeutics, Inc. News & Key Events
Today's Timeline - 06 November
Fri, 00:00 AM
-Analysts maintain Buy ratings for Esperion, citing strong financial performance and growth potential despite insider selling.
Fri, 06:29 AM
-Esperion reports 69% revenue growth in Q3 2025, driven by U.S. product revenue and strategic marketing initiatives.
Insights on Esperion Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -31.33M → 61.83M (in $), with an average increase of 150.7% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ESPR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 64.99M → 168.44M (in $), with an average increase of 25.0% per quarter
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 153.1% return, outperforming this stock by 83.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, ESPR stock has moved down by -4.7%
About Esperion Therapeutics, Inc.
| Organisation | Esperion Therapeutics, Inc. |
| Headquarters | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
| Industry | Health Technology |
| CEO | Mr. Sheldon L. Koenig M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Esperion Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Benjamin Halladay M.B.A. | Chief Financial Officer |
Mr. Glenn P. Brame | Chief Technical Operations Officer |
Tiffany Aldrich M.B.A. | Associate Director of Corporate Communications |
Ms. Betty Jean Swartz | Chief Business Officer |
LeAnne Bloedon M.S. | VP & Head of Development |
Mr. John B. Harlow Jr. | Chief Commercial Officer |
Dr. Stephen Pinkosky | Vice President of Drug Discovery of Early Pre-Clinical Development |
Mr. Sheldon L. Koenig M.B.A. | President, CEO & Director |
FAQs
What is Esperion Therapeutics, Inc. share price today?
Esperion Therapeutics, Inc. share price today is $2.62 as on at the close of the market. Esperion Therapeutics, Inc. share today touched a day high of $2.65 and a low of $2.52.
What is the 52 week high and 52 week low for Esperion Therapeutics, Inc. share?
Esperion Therapeutics, Inc. share touched a 52 week high of $4.18 on and a 52 week low of $0.69 on . Esperion Therapeutics, Inc. stock price today i.e. is closed at $2.62,which is 37.25% down from its 52 week high and 278.34% up from its 52 week low.
What is Esperion Therapeutics, Inc.'s market capitalisation today?
Esperion Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Esperion Therapeutics, Inc. Stock (ESPR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Esperion Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Esperion Therapeutics, Inc. Shares that will get you 0.5725 shares as per Esperion Therapeutics, Inc. share price of $2.62 per share as on April 3, 2026 at 1:29 am IST.
What is the minimum amount required to buy Esperion Therapeutics, Inc. Stock (ESPR) from India?
Indian investors can start investing in Esperion Therapeutics, Inc. (ESPR) shares with as little as ₹93.116 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.16 in Esperion Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Esperion Therapeutics, Inc. share’s latest price of $2.62 as on April 3, 2026 at 1:29 am IST, you will get 3.8168 shares of Esperion Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Esperion Therapeutics, Inc. has given to Indian investors in the last 5 years?
Esperion Therapeutics, Inc. stock has given -90.91% share price returns and 28.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?